Effects of Surgery Combined with Different Chemotherapy on Matrix Metalloproteinase-9 and Tissue Inhibitors of Metalloproteinase-1 in Children with Neuroblastoma
Table 5
Analysis of complication (mean ± SD (n, %)).
Group A (n = 50)
Group B (n = 42)
χ2/t
Myelosuppression stages I-II
27 (54.00)
21 (50.00)
0.146
0.702
Myelosuppression stages III-IV
23 (46.00)
21 (50.00)
CD4+/CD8+
Before chemotherapy
1.71 ± 0.36
1.68 ± 0.39
0.383
0.702
After chemotherapy
0.81 ± 0.21
0.88 ± 0.21
1.593
0.115
After surgery
0.41 ± 0.13#
0.39 ± 0.21#
0.558
0.578
NK cells
Before chemotherapy
8.86 ± 1.14
8.72 ± 0.90
0.645
0.521
After chemotherapy
12.10 ± 1.96
12.21 ± 2.28
0.249
0.804
After surgery
21.79 ± 5.13#
23.15 ± 4.84#
1.300
0.197
Comparison with the same group before chemotherapy, .#Comparison with the same group after chemotherapy, .
